JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

A machine learning-based prediction model for colorectal liver metastasis

  • 0Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Clinical and Experimental Medicine +

|

May 12, 2025

|

May 12, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

This study developed a machine learning model to predict colorectal liver metastasis (CRLM) in colorectal cancer (CRC) patients using routine lab tests. The CRLM-Lab6 model shows high accuracy, aiding early detection and prognosis.

Area Of Science

  • Oncology
  • Medical Informatics
  • Biostatistics

Background

  • Colorectal liver metastasis (CRLM) significantly worsens prognosis in colorectal cancer (CRC).
  • Accurate prediction of CRLM is crucial for timely intervention and improved patient outcomes.
  • Existing prediction methods often lack comprehensive validation or integration with clinical practice.

Purpose Of The Study

  • To develop and validate a machine learning (ML)-based risk prediction model for CRLM using conventional clinical data.
  • To identify key clinical variables predictive of CRLM occurrence.
  • To create a clinically applicable tool for forecasting CRLM risk in CRC patients.

Main Methods

  • Retrospective analysis of clinical data from 865 CRC patients (January 2018 - September 2024).
  • Utilized Least Absolute Shrinkage and Selection Operator (LASSO) regression for variable selection.
  • Developed and compared five ML algorithms, selecting Random Forest for the final model (CRLM-Lab6).
  • Evaluated model performance using ROC curves, precision-recall curves, decision curve analysis, and calibration curves.

Main Results

  • The Random Forest-based CRLM-Lab6 model, incorporating LDH, CA199, ALT, CEA, TBIL, and AGR, demonstrated superior predictive performance.
  • The model achieved an Area Under the Curve (AUC) of 0.94, with a sensitivity of 0.88 and specificity of 0.93.
  • The model was integrated into a web application for enhanced clinical utility.

Conclusions

  • A novel ML-driven risk prediction model (CRLM-Lab6) for CRLM has been successfully developed and validated.
  • The model leverages readily available laboratory test data for accurate and efficient risk assessment.
  • This tool holds significant potential for clinical application in managing CRC patients at risk of liver metastasis.

Keywords: